[In vitro studies of pyrazinamide action on Mycobacteria tuberculosis showing resistance and sensitivity to specific chemotherapy and antibiotics; comparative studies].
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D009525:Niacin / Q000031:analogs & derivatives; D009539:Nicotinic Acids; D011718:Pyrazinamide; D012106:Research; D014376:Tuberculosis
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D009539:Nicotinic Acids; D009525:Niacin; D011718:Pyrazinamide
ANTIBIOTICS/effects; CYTOTOXIC DRUGS/effects; MYCOBACTERIUM TUBERCULOSIS/effect of drugs on; NICOTINIC ACID/related compounds
Indagini in vitro sull'azione della pirazinamide nei confronti dei micobatteri tubercolari sensibili e resistenti ai chemio-antibiotici specifici.